Clinical Trial Applications: Filter, Search, and view applications


Clear
Extended search...

Page 4 of 13, showing 5 Applications out of 61 total, starting on record 16, ending on 20

# Protocol No Study Title Investigator(s) & Site(s) Application Status

16.

ECCT/18/05/02   KINGA Study
    Immunogenetic Modulators of Mucosal Protection from HIV-1: The Kinga Study   
Principal Investigator(s)
1. Nelly Rwamba Mugo
Site(s) in Kenya
KEMRI-CCR - Partners in Health Research & Development (PHRD) Thika Site.
 
Trial Status In follow-up
Protocol Date 28-02-2018
View

17.

ECCT/18/04/02   Maternal Influenza Vaccine Study
    Impact of HIV Infection and Malaria Parasitemia on Immunogenicity of Inactivated Influenza Vaccine in Pregnant Women and on Mother-to-Child Vaccine-induced Antibody Transfer   
Principal Investigator(s)
1. Sandra S Chaves
Site(s) in Kenya
1. Siaya County Referral Hospital (Siaya county)
2. Bondo Sub-County Hospital (Siaya county)
 
Trial Status Recruiting
Protocol Date 03-11-2017
View

18.

ECCT/17/08/06   Enhancing Preventive Therapy of Malaria In children with Sickle cell anemia in East Africa (EPiTOMISE)
    Enhancing Preventive Therapy of Malaria In children with Sickle cell anemia in East Africa (EPiTOMISE)   
Principal Investigator(s)
1. Festus Muigai Njuguna
Site(s) in Kenya
Homa Bay County Hospital
 
Trial Status In follow-up
Protocol Date 27-03-2017
View

19.

ECCT/17/08/01   A trial to compare the safety and immune response of the normal full and reduced doses of yellow fever vaccines in Kenyan adults
    A Phase IV randomized, double blinded non-inferiority trial on the immunogenicity and safety of fractional doses of yellow fever vaccines.   
Principal Investigator(s)
1. Philip Bejon
Site(s) in Kenya
KEMRI Kilifi
 
Trial Status Suspended
Protocol Date 20-04-2017
View

20.

ECCT/17/05/02   The Anza Mapema Study
    Expanding test and treat for HIV prevention in MSM in Kisumu, Kenya: The Anza Mapema Study   
Principal Investigator(s)
1. Fredrick Odhiambo Otieno
Site(s) in Kenya
Anza Mapema Study Clinic
 
Trial Status Writing-up
Protocol Date 20-09-2016
View